-
Endo Pharmaceuticals Inc et al v. Watson Laboratories Inc DC CAFC
- 2:13-cv-00192
- E.D. Tex.
- Judge: Rodney Gilstrap
- Filed: 02/28/2013
- Closed: 10/22/2015
- Latest Docket Entry: 11/21/2016
- PACER
- Docket updated daily
2
Plaintiffs
5
Defendants
1
Accused
Product
2
Patents-in-Suit
967
Days in
Litigation
-
Endo Pharmaceuticals Inc et al v. Watson Laboratories Inc DC CAFC
- 2:13-cv-00192
- E.D. Tex.
- Judge: Rodney Gilstrap
- Filed: 02/28/2013
- Closed: 10/22/2015
- Latest Docket Entry: 11/21/2016
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A composition for topical application having penetration-enhancing properties consisting essentially of:</claim-text> a) an active agent, wherein said active agent is testosterone or derivatives thereof having a concentration of about 0.1% to about
view more
|
Enforceable and Valid (102 and 103)
Entry 142 |
3 |
A composition in accordance with claim 1, wherein said active agent is testosterone.
|
Enforceable and Valid (102 and 103)
Entry 142 |
4 |
A composition in accordance with claim 1, wherein said active agent is present from about 1% to about 2% weight to weight of said composition.
|
Enforceable and Valid (102 and 103)
Entry 142 |
6 |
A composition in accordance with claim 5, wherein said oleic acid is present from about 0.1% to about 5% weight to weight of said composition.
|
Enforceable and Valid (102 and 103)
Entry 142 |
11 |
A composition in accordance with claim 7, wherein said C<HIL><SB>1</SB></HIL>-C<HIL><SB>4 </SB></HIL>alcohol is a mixture of ethanol and isopropanol.
|
Enforceable and Valid (102 and 103)
Entry 142 |
18 |
A composition in accordance with claim 15, wherein said glycol is propylene glycol.
|
Enforceable and Valid (102 and 103)
Entry 142 |
22 |
A composition in accordance with claim 21, wherein said glycol is present from about 30% to about 40% weight to weight of said composition.
|
Enforceable and Valid (102 and 103)
Entry 142 |
28 |
A composition for topical application having penetration-enhancing properties consisting essentially of:</claim-text> a) an active agent, wherein said active agent is testosterone or derivatives thereof having a concentration of about 0.1% to about
view more
|
Enforceable and Valid (102 and 103)
Entry 142 |
Claim # | Claim Text | Outcome |
---|---|---|
19 |
A method for administering a topically or systemically active agent with increased penetration, said method comprising: topically administering to a mammal a composition comprising:</claim-text> a) testosterone or a derivative thereof having a
view more
|
Enforceable and Valid (102 and 103)
Entry 142 |
20 |
A method in accordance with claim <HIL><BOLD>19</BOLD></HIL>, wherein testosterone or a derivative thereof is present in a concentration selected from the group consisting of 0.5%, 1.00%, 1.25%, 1.50% and 2.00% weight to weight of said composition.
|
Enforceable and Valid (102 and 103)
Entry 142 |